These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1657494)

  • 1. Serum calcium oxalate saturation in patients on maintenance haemodialysis for primary hyperoxaluria or oxalosis-unrelated renal diseases.
    Marangella M; Petrarulo M; Vitale C; Daniele PG; Sammartano S; Cosseddu D; Linari F
    Clin Sci (Lond); 1991 Oct; 81(4):483-90. PubMed ID: 1657494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure.
    Marangella M; Vitale C; Petrarulo M; Tricerri A; Cerelli E; Cadario A; Barbos MP; Linari F
    Kidney Int; 1995 Jul; 48(1):182-7. PubMed ID: 7564076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.
    Marangella M; Cosseddu D; Petrarulo M; Vitale C; Linari F
    Nephrol Dial Transplant; 1993; 8(12):1333-7. PubMed ID: 8159301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria.
    Ogawa Y; Machida N; Ogawa T; Oda M; Hokama S; Chinen Y; Uchida A; Morozumi M; Sugaya K; Motoyoshi Y; Hattori M
    Urol Res; 2006 Feb; 34(1):12-6. PubMed ID: 16432691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria.
    Marangella M; Petrarulo M; Cosseddu D; Vitale C; Linari F
    Am J Kidney Dis; 1992 Jun; 19(6):546-53. PubMed ID: 1595703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of assessment of serum calcium oxalate saturation in the hyperoxaluria syndromes.
    Marangella M; Vitale C; Petrarulo M; Linari F
    Nephrol Dial Transplant; 1995; 10 Suppl 8():11-3. PubMed ID: 8592617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
    Milliner D; Hoppe B; Groothoff J
    Urolithiasis; 2018 Aug; 46(4):313-323. PubMed ID: 28718073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolate determination detects type I primary hyperoxaluria in dialysis patients.
    Marangella M; Petrarulo M; Bianco O; Vitale C; Finocchiaro P; Linari F
    Kidney Int; 1991 Jan; 39(1):149-54. PubMed ID: 2002628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral and intravenous calcitriol on serum calcium oxalate saturation in dialysis patients.
    Marangella M; Vitale C; Cosseddu D; Petrarulo M; Linari F
    Clin Sci (Lond); 1993 Sep; 85(3):309-14. PubMed ID: 8403803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1.
    Yamauchi T; Quillard M; Takahashi S; Nguyen-Khoa M
    Nephrol Dial Transplant; 2001 Dec; 16(12):2407-11. PubMed ID: 11733634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.
    Worcester EM; Nakagawa Y; Bushinsky DA; Coe FL
    J Clin Invest; 1986 Jun; 77(6):1888-96. PubMed ID: 3711339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria.
    Hoppe B; Kemper MJ; Bökenkamp A; Langman CB
    Kidney Int; 1998 Sep; 54(3):921-5. PubMed ID: 9734617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation in primary hyperoxaluria.
    Watts RW; Morgan SH; Mansell MA; Purkiss P
    Ann Acad Med Singap; 1987 Apr; 16(2):337-9. PubMed ID: 3318661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure.
    Tomson CR; Channon SM; Parkinson IS; Morley AR; Lennard TW; Parrott NR; Laker MF
    J Clin Pathol; 1988 Oct; 41(10):1107-13. PubMed ID: 3192733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma oxalate concentration in chronic renal disease.
    Boer P; van Leersum L; Hené RJ; Mees EJ
    Am J Kidney Dis; 1984 Sep; 4(2):118-22. PubMed ID: 6383028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.
    Marangella M; Petrarulo M; Mandolfo S; Vitale C; Cosseddu D; Linari F
    Nephron; 1992; 60(1):74-80. PubMed ID: 1738418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis.
    Pape L; Ahlenstiel-Grunow T; Birtel J; Krohne TU; Hoppe B
    Pediatr Nephrol; 2020 Jun; 35(6):1121-1124. PubMed ID: 32107618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraplegia as a presentation of primary hyperoxaluria.
    Dieudonné Y; Eprinchard L; Léon E; Oswald P; Gressel A; Carre S; Dimitrov Y
    CEN Case Rep; 2018 Nov; 7(2):313-315. PubMed ID: 29959618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.